Literature DB >> 25833468

Patterns and functional roles of LINE-1 and Alu methylation in the keratinocyte from patients with psoriasis vulgaris.

Surasak Yooyongsatit1, Kriangsak Ruchusatsawat2, Nopadon Noppakun3, Nattiya Hirankarn4, Apiwat Mutirangura5, Jongkonnee Wongpiyabovorn4.   

Abstract

Alterations in LINE-1 methylation are related to many diseases. The levels and patterns of LINE-1 hypomethylation were associated with a higher risk in developing several cancers, having a poorer prognosis and more aggressiveness. To evaluate the LINE-methylated status in psoriasis, LINE-1 methylation in various cells from patients with psoriasis, squamous cell carcinoma and normal controls were assessed by combined bisulfite restriction analysis of LINE-1. The results of the epigenetic changes for intragenic LINE-1 gene expression were also tested on two known expression microarrays. In patients with psoriasis, hypomethylation of LINE-1 and increase in %(u)C(u)C were prominent in the keratinocytes when compared with normal controls (P=0.014 and P=0.020, respectively). Alternatively, %(u)C(m)C was significantly lower in patients with severe psoriasis compared with mild psoriasis (P=0.022). The receiver-operating characteristic curve analysis indicated the high specificity and sensitivity of (u)C(u)C and (u)C(m)C in detecting psoriasis and severity of psoriasis. From expression array analysis, genes with LINE-1 were downregulated more than those genes without LINE-1 (P=3.84 × 10(-27) and P=2.14 × 10(-21), respectively). Modification in LINE-1 methylation may alter the gene expression resulting in a phenotypic change of the psoriatic skin. %(u)C(u)C and %(u)C(m)C may be used as biomarkers for psoriasis.

Entities:  

Mesh:

Year:  2015        PMID: 25833468     DOI: 10.1038/jhg.2015.33

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  36 in total

1.  Antisense promoter of human L1 retrotransposon drives transcription of adjacent cellular genes.

Authors:  M Speek
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

2.  Line-1 hypomethylation in multistage carcinogenesis of the uterine cervix.

Authors:  Shanop Shuangshoti; Nusara Hourpai; Ubon Pumsuk; Apiwat Mutirangura
Journal:  Asian Pac J Cancer Prev       Date:  2007 Apr-Jun

3.  Abnormal histone modifications in PBMCs from patients with psoriasis vulgaris.

Authors:  Peng Zhang; Yuwen Su; Ming Zhao; Wei Huang; Qianjin Lu
Journal:  Eur J Dermatol       Date:  2011 Jul-Aug       Impact factor: 3.328

4.  Parakeratosis in skin is associated with loss of inhibitor of differentiation 4 via promoter methylation.

Authors:  Kriangsak Ruchusatsawat; Jongkonnee Wongpiyabovorn; Phantipa Protjaroen; Mookda Chaipipat; Shanop Shuangshoti; Paul Scott Thorner; Apiwat Mutirangura
Journal:  Hum Pathol       Date:  2011-06-12       Impact factor: 3.466

5.  Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis.

Authors:  Krisanee Chalitchagorn; Shanop Shuangshoti; Nusara Hourpai; Narisorn Kongruttanachok; Pisit Tangkijvanich; Duangporn Thong-ngam; Narin Voravud; Virote Sriuranpong; Apiwat Mutirangura
Journal:  Oncogene       Date:  2004-11-18       Impact factor: 9.867

6.  Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study.

Authors:  Lee E Moore; Ruth M Pfeiffer; Cristina Poscablo; Francisco X Real; Manolis Kogevinas; Debra Silverman; Reina García-Closas; Stephen Chanock; Adonina Tardón; Consol Serra; Alfredo Carrato; Mustafa Dosemeci; Montserrat García-Closas; Manel Esteller; Mario Fraga; Nathaniel Rothman; Núria Malats
Journal:  Lancet Oncol       Date:  2008-03-12       Impact factor: 41.316

Review 7.  DNA methylation in cancer: too much, but also too little.

Authors:  Melanie Ehrlich
Journal:  Oncogene       Date:  2002-08-12       Impact factor: 9.867

8.  A subset of methylated CpG sites differentiate psoriatic from normal skin.

Authors:  Elisha D O Roberson; Ying Liu; Caitriona Ryan; Cailin E Joyce; Shenghui Duan; Li Cao; Ann Martin; Wilson Liao; Alan Menter; Anne M Bowcock
Journal:  J Invest Dermatol       Date:  2011-11-10       Impact factor: 8.551

9.  Hypomethylation of intragenic LINE-1 represses transcription in cancer cells through AGO2.

Authors:  Chatchawit Aporntewan; Chureerat Phokaew; Jittima Piriyapongsa; Chumpol Ngamphiw; Chupong Ittiwut; Sissades Tongsima; Apiwat Mutirangura
Journal:  PLoS One       Date:  2011-03-15       Impact factor: 3.240

10.  Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways.

Authors:  Rajan P Nair; Kristina Callis Duffin; Cynthia Helms; Jun Ding; Philip E Stuart; David Goldgar; Johann E Gudjonsson; Yun Li; Trilokraj Tejasvi; Bing-Jian Feng; Andreas Ruether; Stefan Schreiber; Michael Weichenthal; Dafna Gladman; Proton Rahman; Steven J Schrodi; Sampath Prahalad; Stephen L Guthery; Judith Fischer; Wilson Liao; Pui-Yan Kwok; Alan Menter; G Mark Lathrop; Carol A Wise; Ann B Begovich; John J Voorhees; James T Elder; Gerald G Krueger; Anne M Bowcock; Gonçalo R Abecasis
Journal:  Nat Genet       Date:  2009-01-25       Impact factor: 38.330

View more
  10 in total

Review 1.  Epigenetics in Non-tumor Immune-Mediated Skin Diseases.

Authors:  M C Ovejero-Benito; E Daudén; Alejandra Reolid; E Muñoz-Aceituno; F Abad-Santos
Journal:  Mol Diagn Ther       Date:  2021-03-01       Impact factor: 4.074

2.  The association between Alu hypomethylation and the severity of hypertension.

Authors:  Jirapan Thongsroy; Apiwat Mutirangura
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

3.  Epigenetic modification of long interspersed elements-1 in cumulus cells of mature and immature oocytes from patients with polycystic ovary syndrome.

Authors:  Kamthorn Pruksananonda; Artisa Wasinarom; Wisan Sereepapong; Porntip Sirayapiwat; Prakasit Rattanatanyong; Apiwat Mutirangura
Journal:  Clin Exp Reprod Med       Date:  2016-06-23

4.  Epigenome-wide association data implicates DNA methylation-mediated genetic risk in psoriasis.

Authors:  Fusheng Zhou; Changbing Shen; Jingkai Xu; Jing Gao; Xiaodong Zheng; Randy Ko; Jinfa Dou; Yuyan Cheng; Caihong Zhu; Shuangjun Xu; Xianfa Tang; Xianbo Zuo; Xianyong Yin; Yong Cui; Liangdan Sun; Lam C Tsoi; Yi-Hsiang Hsu; Sen Yang; Xuejun Zhang
Journal:  Clin Epigenetics       Date:  2016-12-05       Impact factor: 6.551

5.  Cytosolic RNA:DNA Duplexes Generated by Endogenous Reverse Transcriptase Activity as Autonomous Inducers of Skin Inflammation in Psoriasis.

Authors:  Jean-Pierre Molès; Anthony Griez; Jean-Jacques Guilhou; Céline Girard; Nicolas Nagot; Philippe Van de Perre; Pierre Dujols
Journal:  PLoS One       Date:  2017-01-17       Impact factor: 3.240

6.  EnHERV: Enrichment analysis of specific human endogenous retrovirus patterns and their neighboring genes.

Authors:  Pumipat Tongyoo; Yingyos Avihingsanon; Santhitham Prom-On; Apiwat Mutirangura; Wuttichai Mhuantong; Nattiya Hirankarn
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

7.  Epigenome-wide DNA methylation regulates cardinal pathological features of psoriasis.

Authors:  Aditi Chandra; Swapan Senapati; Sudipta Roy; Gobinda Chatterjee; Raghunath Chatterjee
Journal:  Clin Epigenetics       Date:  2018-08-09       Impact factor: 6.551

Review 8.  The Pathogenic Role of Dysregulated Epigenetic Modifications in Autoimmune Diseases.

Authors:  Haijing Wu; Yongjian Chen; Huan Zhu; Ming Zhao; Qianjin Lu
Journal:  Front Immunol       Date:  2019-09-27       Impact factor: 7.561

9.  Methylation Status of Alu and LINE-1 Interspersed Repetitive Sequences in Behcet's Disease Patients.

Authors:  Şahru Yüksel; Selma Ozbek Kucukazman; Gülten Sungur Karataş; Mehmet Akif Ozturk; Sasiprapa Prombhul; Nattiya Hirankarn
Journal:  Biomed Res Int       Date:  2016-03-30       Impact factor: 3.411

Review 10.  Methyltransferases in the Pathogenesis of Keratinocyte Cancers.

Authors:  Eun Kyung Ko; Brian C Capell
Journal:  Cancers (Basel)       Date:  2021-07-07       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.